--- title: Phase II Clinical Trials CROs path: /services/phase-2-clinical-trials companies_count: 87 --- # Phase II Clinical Trials CROs 87 published CROs match Phase II Clinical Trials. Locations in this set include United States, India, United Kingdom, Australia, China, and France. Capabilities that show up most often in this set: Small Molecule, Biologics (Other), Gene Therapy, Cell Therapy, and Vaccine. ## Matching companies - [Accelsiors](/companies/accelsiors) - Full-service CRO providing clinical trial management, regulatory consulting, pharmacovigilance, biostatistics, and medical writing across 40+ countries with AI-secure eClinical systems and patient-centered trial design. - [Accutest Research Laboratories](/companies/accutestglobal) - Independent Indian CRO focused on BA/BE studies, Phase II–IV clinical development, and biologics bioanalysis. Operates 262 clinic beds and 21 LC-MS/MS systems across Mumbai and Vadodara. - [Acromion Gmbh](/companies/acromion-gmbh) - European full-service CRO supporting clinical development from Phase I to IV and non-interventional studies, with expertise in clinical monitoring, data management, biostatistics, medical writing, and regulatory affairs. - [Advanced Clinical](/companies/advancedclinical) - Global CRO and FSP provider with 25+ years of experience delivering integrated clinical research solutions across North America, Europe, LATAM, and APAC. - [Aldeyra Therapeutics](/companies/aldeyra) - Biopharmaceutical company developing immunomodulatory therapies for immune-mediated ocular and systemic diseases, with late-stage clinical candidates targeting dry eye disease, allergic conjunctivitis, and retinal conditions. - [Aliri Bioanalysis](/companies/aliribio) - Bioanalytical CRO specializing in PK/PD, biomarker, and spatial imaging services across discovery through Phase 3 clinical trials, with 20+ years of regulatory expertise. - [Allucent](/companies/allucent) - Allucent is a full-service CRO specializing in clinical development solutions for small and mid-sized biotech companies. - [Altasciences](/companies/altasciences) - Mid-size early phase CRO/CDMO in Canada and the U.S. offering preclinical safety testing, clinical pharmacology (Phase I–II), bioanalysis, research services, and manufacturing with integrated capabilities. - [Avion](/companies/avion) - Full-service CRO specializing in clinical trial management, advanced medical imaging, dosimetry, and data management across oncology, dermatology, and radiopharmaceutical therapies. - [BioAgile Therapeutics](/companies/bioagiletherapeutics) - ISO 9001:2015-certified CRO offering end-to-end clinical research services including Phase I–IV trials, medical writing, biostatistics, data management, and regulatory support across pharmaceuticals, nutraceuticals, devices, and biotech. - [BioPharma Services Inc.](/companies/biopharmaservices) - Full-service Phase 1 CRO specializing in early-stage clinical trials, bioequivalence/bioavailability studies, and human abuse potential assessments with state-of-the-art facilities in Toronto and in-house bioanalytical labs. - [CMIC HOLDINGS Co., Ltd.](/companies/cmicgroup) - CMIC HOLDINGS is a Japanese healthcare group whose Pharmaceutical Solutions cover consulting, non-clinical CRO, CRO, CDMO, SMO and CSO services. The group says it supports pharmaceutical companies across the value chain from non-clinical stages through post-marketing. - [CTI Clinical Trial and Consulting Services](/companies/ctifacts) - Full-service CRO founded in 1999 providing therapeutic expertise across clinical trial and consulting services to pharmaceutical and biotechnology companies. - [Caidya](/companies/caidya) - Caidya is a global, full-service CRO delivering personalized clinical development solutions across all phases of clinical research. - [Cardiovascular Clinical Sciences](/companies/ccstrials) - Specialized cardiovascular CRO offering full-spectrum clinical development from protocol design through regulatory submission, with deep cardiology expertise and core laboratory services across all development phases. - [Celerion](/companies/celerion) - Global CRO specializing in early-phase clinical research and bioanalytical sciences with 650+ beds across 30 countries and 50+ years of experience. - [Certara](/companies/certara) - Certara transforms drug development with proprietary biosimulation software, predictive modeling, and AI-driven services spanning discovery through commercialization. Serving 2,400+ biopharmaceutical companies and regulatory agencies across 70 countries, Certara's model-informed drug development (MIDD) platform accelerates clinical and regulatory decision-making. - [Citeline](/companies/citeline) - Citeline provides clinical trial intelligence, planning, feasibility, patient engagement, and regulatory compliance solutions to pharmaceutical sponsors. The platform delivers benchmarking across 400k+ trials, site selection, protocol optimization, and disclosure management services. - [Clario](/companies/clario) - Clario provides comprehensive clinical trial endpoint solutions spanning cardiac safety, eCOA, medical imaging, respiratory, and precision motion analysis, supporting approximately 70% of FDA and EMA novel drug approvals over the past decade. - [ClinActis Pte Ltd](/companies/clinactis) - Full-service CRO delivering clinical trial services across Asia Pacific, with 50+ years of cumulative experience managing Phase I–IV trials and expertise in oncology, cardiovascular, CNS, and infectious disease indications.